IGC Pharma IGC
NYSE IGC
$0.31 +0.03 (+11.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

IGC Pharma (IGC) Change in Acquisitions & Divestments (2012 - 2021)

IGC Pharma (IGC) posted quarterly Change in Acquisitions & Divestments of -$3.0 million for Q1 2021, down 264.0% quarter-over-quarter from $1.8 million in Q4 2020.

IGC Pharma (IGC) Change in Acquisitions & Divestments (2012 - 2021) Analysis & Trends

IGC Pharma (IGC) has reported Change in Acquisitions & Divestments for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2021.

  • In Q1 2021, Change in Acquisitions & Divestments changed N/A year-over-year to -$3.0 million; the TTM figure through Mar 2022 stood at -$1.2 million (down 2.33% YoY), while the FY2021 annual figure was $47000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments slipped to -$3.0 million in Q1 2021 per IGC's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.8 million in Q4 2020 and bottomed at -$3.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 IGC Pharma 30.17 Mn 29.90 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 -3.03 Mn
Mar 31, 2021 -3.03 Mn
Dec 31, 2020 1.85 Mn
Dec 31, 2020 1.85 Mn
Dec 31, 2016 27,000.00
Dec 31, 2016 27,000.00
Jun 30, 2016 -55,000.00
Jun 30, 2016 -55,000.00
Mar 31, 2016 -76,290.00
Mar 31, 2016 -76,290.00
Mar 31, 2013 -28,010.00
Mar 31, 2013 -28,010.00
Jun 30, 2012 244,223.00
Jun 30, 2012 244,223.00